The investigation to determine the causes of the death of a medical student several days after being vaccinated against Covid-19 with the AstraZeneca vaccine has been transferred from the Nantes prosecutor's office to the Paris prosecutor's office

The investigation to determine the causes of the death of a medical student several days after being vaccinated against Covid-19 with the AstraZeneca vaccine has been transferred from the Nantes prosecutor's office to the Paris prosecutor's office, announced Wednesday the lawyer for family.

"We seized the local prosecution for the sake of speed of our complaints to have autopsies by then asking them to transfer the file to Paris", explained to AFP Me Etienne Boittin, lawyer of the family.

"We have written confirmation of Anthony's transfer (the Nantes student who died on March 18, editor's note) and the other files should reasonably follow the same fate," added the lawyer.

>> LIVE

 - Coronavirus: follow the evolution of the situation Wednesday April 28

The lawyer says he has been seized of about fifteen cases of people who died in France 

The Paris prosecutor's office has a public health center, which is not the case with the Nantes prosecutor's office.

The results of the autopsy of the young man who died at 26 years old should be known "within a few days", according to the same source.

The lawyer said to be seized of fifteen cases of people who died in France after having been vaccinated at AstraZeneca, overwhelmingly "under 60 years", said the lawyer installed in Saint-Nazaire, stressing that the families of the victims are now eager to "know the conclusions of the autopsies".

On Monday, the European Union announced that it had sued the AstraZeneca laboratory for not having kept its commitments on deliveries of its anti-Covid vaccine, a procedure that the Swedish-British group immediately deemed "unfounded". The use of the AstraZeneca vaccine has been restricted in most countries of the European Union due to the very rare cases of thrombosis it can cause. Denmark no longer uses it.